Gilfillan C - Search Results

1

'First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer.

Lomax AJ, Parente P, Gilfillan C, Livingston PM, Davis ID, Pezaro C. Lomax AJ, et al. Among authors: gilfillan c. Intern Med J. 2016 Feb;46(2):141-8. doi: 10.1111/imj.12731. Intern Med J. 2016. PMID: 25732203 Review.

2

Fracture prevention strategies in patients presenting to Australian hospitals with minimal-trauma fractures: a major treatment gap.

Teede HJ, Jayasuriya IA, Gilfillan CP. Teede HJ, et al. Among authors: gilfillan cp. Intern Med J. 2007 Oct;37(10):674-9. doi: 10.1111/j.1445-5994.2007.01503.x. Intern Med J. 2007. PMID: 17894764

3

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.

Grossmann M, Hamilton EJ, Gilfillan C, Bolton D, Joon DL, Zajac JD. Grossmann M, et al. Among authors: gilfillan c. Med J Aust. 2011 Mar 21;194(6):301-6. doi: 10.5694/j.1326-5377.2011.tb02979.x. Med J Aust. 2011. PMID: 21426285 Review.

4

Mutation profile of differentiated thyroid tumours in an Australian urban population.

Mond M, Alexiadis M, Fuller PJ, Gilfillan C. Mond M, et al. Among authors: gilfillan c. Intern Med J. 2014 Aug;44(8):727-34. doi: 10.1111/imj.12476. Intern Med J. 2014. PMID: 24862939

5

A 7-day team-based model of care in general medicine: implementation and outcomes at 12 months.

Gilfillan C, Newnham E, Nagappan R, Evans J, Compton J. Gilfillan C, et al. Intern Med J. 2016 Jan;46(1):79-85. doi: 10.1111/imj.12913. Intern Med J. 2016. PMID: 26386271

6

Author reply 'First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer.

Lomax AJ, Parente P, Gilfillan C, Livingston PM, Davis ID, Pezaro C. Lomax AJ, et al. Among authors: gilfillan c. Intern Med J. 2016 Apr;46(4):507-8. doi: 10.1111/imj.13035. Intern Med J. 2016. PMID: 27062210 No abstract available.

7

Subclinical hypothyroidism during pregnancy: the Melbourne public hospitals consensus.

Hamblin PS, Sheehan PM, Allan C, Houlihan CA, Lu ZX, Forehan SP, Topliss DJ, Gilfillan C, Krishnamurthy B, Renouf D, Sztal-Mazer S, Varadarajan S. Hamblin PS, et al. Among authors: gilfillan c. Intern Med J. 2019 Aug;49(8):994-1000. doi: 10.1111/imj.14210. Intern Med J. 2019. PMID: 30561039

8

Tumour necrosis factor-alpha inhibitor induced recurrent symptomatic hypoglycaemia.

Mah JY, Teng J, Gilfillan C. Mah JY, et al. Among authors: gilfillan c. Intern Med J. 2019 Nov;49(11):1460-1461. doi: 10.1111/imj.14636. Intern Med J. 2019. PMID: 31713334 No abstract available.

9

Inpatient insulin initiation using a hospital in the home unit.

Montalto M, Gilfillan CP, Dutta D, Cole S, Avery C, Smith SV. Montalto M, et al. Among authors: gilfillan cp. Intern Med J. 2001 Nov;31(8):492-4. doi: 10.1046/j.1445-5994.2001.00106.x. Intern Med J. 2001. PMID: 11720064 No abstract available.

10

A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).

Loganathan J, Cohen AC, Kaloupis GM, Harris C, Chronopoulos A, James V, Hamilton J, Green S, Wallis A, Morgan S, Dauer R, Gilfillan C, Dear AE. Loganathan J, et al. Among authors: gilfillan c. J Diabetes Complications. 2022 May;36(5):108188. doi: 10.1016/j.jdiacomp.2022.108188. Epub 2022 Mar 30. J Diabetes Complications. 2022. PMID: 35382966 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters